Detection of mitomycin c-DNA adducts in vivo by 32P-postlabeling: Time course for formation and removal of adducts and biochemical modulation

Cancer Research

Volumn 58, Issue 3, 1998, Pages 453-461

  Warren, Amy J ^a,b   Maccubbin, Alexander E ^d   Hamilton, Joshua W ^a,b,c  

^a Dartmouth College   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3',4,4' TETRACHLOROBIPHENYL; ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; DEXAMETHASONE; ETACRYNIC ACID; GLUTETHIMIDE; MITOMYCIN C; PHOSPHORUS 32;

ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; DNA ADDUCT; DNA CROSS LINKING; DNA DETERMINATION; DNA DRUG COMPLEX; DRUG DETERMINATION; DRUG DNA BINDING; DRUG METABOLISM; EMBRYO; ISOTOPE LABELING; KIDNEY; LUNG; NONHUMAN; PRIORITY JOURNAL; SALMON; TISSUE DISTRIBUTION;

ACETYLCYSTEINE; ANIMALS; BIOTRANSFORMATION; BUTHIONINE SULFOXIMINE; CHICK EMBRYO; CROSS-LINKING REAGENTS; DEXAMETHASONE; DNA; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; ENZYME INDUCTION; ETHACRYNIC ACID; GLUTATHIONE; GLUTETHIMIDE; KIDNEY; LIVER; LUNG; METABOLIC DETOXICATION, DRUG; MITOMYCIN; PHOSPHORUS RADIOISOTOPES; POLYCHLORINATED BIPHENYLS; TIME FACTORS;

EID: 0032006839     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Tomasz, M., Lipman, R., Chowdary, D., Pawlak. J., Verdine, G. L., and Nakanishi, K. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science (Washington DC), 235: 1204-1208, 1987.
2. Tomasz, M., and Lipman, R. Reassignment of the guanine binding mode of reduced mitomycin C. Biochemistry, 25: 4337-4344, 1986.
3. Bizanek, R., McGuinness, B. F., Nakanishi, K., and Tomasz, M. Isolation and structure of an intrastrand cross-link adduct of mitomycin C and DNA. Biochemistry, 31: 3084-3091, 1992.
4. Doll, C. D., Weiss, R. B., and Issell, B. F. Mitomycin: ten years after approval for marketing. J. Clin. Oncol., 3: 276-286, 1984.
5. Iyer, V. N., and Szybalski, W. Mitomycins and porfiromycin: chemical mechanism of activation and cross-linking of DNA. Science (Washington DC), 145: 55-58, 1964.
6. Hamilton, J. W., and Wetterhahn, K. E. Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage. Mol. Carcinog., 2: 274-286, 1989.
7. McCaffrey, J., Wolf, C. M., and Hamilton, J. W. Effects of the genotoxic carcinogen chromium(VI) on basal and hormone-inducible phosphoenolpyruvate carboxykinase gene expression in vivo: correlation with glucocorticoid-and developmentally-regulated expression. Mol. Carcinog., 10: 189-198, 1994.
8. Caron, R. M., and Hamilton, J. W. Preferential effects of the chemotherapeutic DNA crosslinking agent mitomycin C on inducible gene expression in vivo. Environ. Mol. Mutagen., 25: 4-11, 1995.
9. 32P-Postlabeling methods for DNA adduct detection: overview and critical evaluation. Drug Metab. Rev., 26: 67-85, 1994.
10. Keith, G., and Dirheimer, G. Postlabeling: a sensitive method for studying DNA adducts and their role in carcinogenesis. Curr Opin. Biotechnol., 6: 3-11, 1995.
11. Maccubbin, A. E., Mudipalli, A., Nadadur, S. S., Ersing, N., and Gurtoo, H. L. Mutations induced in a shuttle vector plasmid exposed to monofunctionally activated mitomycin C. Environ. Mol. Mutagen., 29: 143-151, 1997.
12. 2G interstrand crosslink in a model synthetic 23 base pair oligonucleotide DNA duplex. Chem. Res. Toxicol., 9: 1063-1071, 1996.
13. Tomasz, M., Chawla, A. K., and Lipman, R. Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin C. Biochemistry, 27: 3182-3187, 1988.
14. Hamilton, J. W., Denison, M. S., and Bloom, S. E. Development of basal and induced aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity in the chicken embryo in ovo. Proc. Natl. Acad. Sci. USA, 80: 3372-3376, 1983.
15. Hamilton, J. W., Bement, W. J., Sinclair, P. R., Sinclair, J. F., and Wetterhahn, K. E. Expression of 5-aminolaevulinate synthase and cytochrome P-450 in chicken embryo hepatocytes in vivo and in cell culture: effect of porphyrinogenic drugs and haem. Biochem. J., 255: 267-275, 1988.
16. Misra, M., Alcedo, J. A., and Wetterhahn, K. E. Two pathways for chromium(VI)-induced DNA damage in 14 day chick embryos: Cr-DNA binding in liver and 8-oxo-2′-deoxyguanosine in red blood cells. Carcinogenesis (Lond.), 15: 2911-2917, 1994.
17. Hissin, P. J., and Hilf, R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem., 74: 214-226, 1976.
18. Benson, A. M., Hunkeler, M. J., and Talalay, P. Increase in NAD(P)H quinone reductase by dietary oxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA, 77: 5216-5220, 1980.
19. Tomasz, M., Lipman, R., Snyder, J. K., and Nakanishi, J. Full structure of a mitomycin C dinucleoside phosphate adduct. Use of differential FT-IR spectroscopy in microscale structural studies. J. Am. Chem. Soc., 105: 2059-2063, 1983.
20. Kumar, S., Lipman, R., and Tomasz, M. Recognition of specific DNA sequences by mitomycin C for alkylation. Biochemistry, 31: 1399-1407, 1992.
21. Borowy-Borowski, H., Lipman, R., Chowdary, D., and Tomasz, M. Duplex oligodeoxyribonucleotides cross-linked to mitomycin C at a single site: synthesis, properties, and cross-link reversibility. Biochemistry, 29: 2992-2999, 1990.
22. Hamilton, J. W., Bernent, W. J., Sinclair, P. R., Sinclair, J. F., Alcedo, J. A., and Wetterhahn, K. E. Inhibition of protein synthesis increases the transcription of the phenobarbital-inducible CYP2H1 and CYP2H2 genes in chick embryo hepatocytes Arch. Biochem. Biophys., 298: 96-104, 1992.
23. Gilday, D., Gannon, M., Yutzey, K., Bader, D., and Rifkind, A. B. Molecular cloning and expression of two novel avian cytochrome P450 1A enzymes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem., 271: 33054-33059, 1996.
24. Sinclair, J., and Sinclair, P. Avian cytochrome P-450. In: J. Schenkman and H. Greim (eds.), Cytochrome P450. Heidelberg: Springer-Verlag, 1993.
25. Parkinson, A. Biotransformation of xenobiotics. In: C. D. Klaassen, M. O. Amdur, and J. Doull (eds.), Casarett and Doull's Toxicology: The Basic Science of Poisons, pp. 139-162. New York: McGraw-Hill, 1996.
26. Tomasz, M., Lipman, R., McGuinness, B. F., and Nakanishi, K. Isolation and characterization of a major adduct between mitomycin C and DNA. J. Am. Chem. Soc., 110: 5892-5896, 1988.
27. 3H]-porfiromycin adducts of EMT6 mouse mammary tumor cell DNA: effects of hypoxia and dicumerol on adduct patterns. Cancer Commun., 3: 213-223, 1991.
28. Bizanek, R., Chowdary, D., Arai, H., Kasai, M., Hughes, C. S., Sartorelli, A. C., Rockwell, S., and Tomasz, M. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns. Cancer Res., 53: 5127-5134, 1993.
29. Dorr, R. T., Bowden, G. T., Alberts, D. S., and Liddil, J. D. Interactions of mitomycin C with mammalian DNA detected by alkaline elution. Cancer Res., 45: 3510-3516, 1985.
30. 32P-postlabeling analysis. Mutat. Res., 202: 85-91, 1988.
31. Pan, S., Yu, F., and Hipsher, C. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells. Mol. Pharmacol., 43: 870-877, 1993.
32. 32P analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C. Mutat. Res., 179: 75-88, 1987.
33. den Hartigh, J., McVie, J. G., van Ort, W. J., and Pinedo, H. M. Pharmacokinetics of mitomycin C in humans. Cancer Res., 43: 5017-5021, 1983.
34. Bestor, T. H. Methylation patterns in the vertebrate genome. J NIH Res., 5: 57-60, 1993.
35. 5CpG dinucleotide sequence in DNA by mitomycin C for alkylation and cross-linking. Bioorg. Med. Chem., 3: 851-860, 1995.
36. Romanoff, A. Biochemistry of the Avian Embryo. New York: John Wiley and Sons, 1967.
37. Hamilton, J. W., and Bloom, S. E. Correlation between induction of xenobiotic metabolism and DNA damage from chemical carcinogens in the chick embryo in vivo. Carcinogenesis (Lond.), 7: 1101-1106, 1986.
38. Strauss, B. S. DNA repair: the nick in time. Nature (Lond.), 366: 301, 1993.
39. Hanawalt, P. C. Transcription-coupled repair and human disease. Science (Washington DC), 266: 1957-1958, 1994.
40. Ramos, L. A., Lipman, R., Tomasz, M., and Basu, A. K. Effect of a site-specifically located mitomycin C-DNA adduct in Escherichia coli. Proc. Am. Assoc. Cancer Res., 38: 182, 1997.
41. Maccubbin, A. E., Schimert, P., Woodman, W., Ersing, N., and Gurtoo, H. L. Formation and repair of DNA adducts in cells treated with mitomycin C. Proc. Am. Assoc. Cancer Res., 38: 449, 1997.
42. Hamilton, J. W., and Wetterhahn, K. E Chromium(VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis (Lond.), 7: 2085-2088, 1986.
43. Komiyama, T., Oki, T., and Inui, T. Activation of mitomycin C and quinone drug metabolism by NADPH-cytochrome P-450 reductase. J. Pharmacol. Dyn., 2: 407-410, 1979.
44. Pan, S., Andrews, P. A., Glover, C. J., and Bachur, N. R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem., 259: 959-966, 1984.
45. Keyes, S. R., Fracasso, P. M., Heimbrook, D. C., Rockwell, S., Sligar, S. G., and Sartorelli, A. C. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res., 44: 5638-5643, 1984.
46. Begleiter, A., and Leith, M. K. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions. Mol. Pharmacol., 44: 210-215, 1993.
47. Gustafson, D. L., and Pritsos, C. A. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J. Natl. Cancer Inst., 84: 1180-1185, 1992.
48. Gustafson, D. L., and Pritsos, C. A. Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarol. Cancer Res., 52: 6936-6939, 1992.
49. Gustafson, D. L., and Pritsos, C. A. Kinetics and mechanism of mitomycin C bioactivation by xanthine dehydrogenase under aerobic and hypoxic conditions. Cancer Res., 53: 5470-5474, 1993.
50. Goeptar, A. R., Groot, E. J., Scheerens, H., Commandeur, J. N. M., and Vermeulen, N. P. E. Cytotoxicity of mitomycin C and Adriamycin in freshly isolated rat hepatocytes: the role of cytochrome P450. Cancer Res., 54: 2411-2418, 1994.
51. 5 reductase. Cancer Res., 53: 4907-4912, 1993.
52. Siegel, D., Beall, H., Senekowitsch, C., Kasai, M., Arai, H., Gibson, N. W., and Ross, D. Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry, 31: 7879-7885, 1992.
53. Siegel, D., Gibson, N. W., Preusch, P. C., and Ross, D. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res., 50: 7483-7489, 1990.
54. Prakash, A. S., Beall, H., Ross, D., and Gibson, N. W. Sequence-selective alkylation and cross-linking induced by mitomycin C upon activation by DT-diaphorase. Biochemistry, 32: 5518-5525, 1993.
55. Robertson, N., Stratford, I. J., Houlbrook, S., Carmichael, J., and Adams, G. E. The sensitivity of human tumour cells to quinone bioreductive drugs: what role for DT-diaphorase? Biochem. Pharmacol., 44: 409-412, 1992.
56. Powis, G., Gasdaska, P. Y., Gallegos, A., Sherrill, K., and Goodman, D. Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increases in anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs. Anticancer Res., 15: 1141-1145, 1995.
57. Sharma, M., and Tomasz, M. Conjugation of glutathione and other thiols with bioreductively activated mitomycin C. Effect of thiols on the reductive activation rate. Chem. Res. Toxicol., 7: 390-400, 1994.
58. Sharma, M., He, Q., and Tomasz, M. Effects of glutathione on alkylation and cross-linking of DNA by mitomycin. Isolation of a ternary glutathione-mitomycin-DNA adduct. Chem. Res. Toxicol., 7: 401-407, 1994.
59. Singh, S. V., Xu, B. H., Maurya, A. K., and Mian, A. M. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid. Biochim. Biophys. Acta, 1137: 257-263, 1992.
60. Xu, B. H., and Singh, S. V. Effect of buthionine sulfoximine and ethacrynic acid on cylotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067. Cancer Res., 52: 6666-6670, 1992.
61. Perry, R. R., Kang, Y., and Greaves, B. Biochemical characterization of a mitomycin C resistant colon cancer cell line variant. Biochem. Pharmacol., 46: 1999-2005, 1993.
62. Perry, R. R., Greaves, B. R., Rasberry, U., and Barranco, S. C. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro. Cancer Res., 52: 4608-4612, 1992.
63. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313-4320, 1994.
64. McCaffrey, J., and Hamilton, J. W. Developmental regulation of basal and hormone-inducible phosphoenolpyruvate carboxykinase gene expression in chick embryo liver in vivo. Arch. Biochem. Biophys., 309: 10-17, 1994.